Sees Q4 System-wide comparable RevPAR, on a currency neutral basis 1.0%-2.0% vs. last year, and Adjusted EBITDA $804M-$834M.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLT: